-transparent.png){kind=logo}
The endometrial carcinoma cell lines EC-MZ-1, 2, 3, 5, 9, and 11 were established between 1986 and 1990. Four cell cultures were started from endometrial tissue, one from ascites, and one from a lymph node metastasis. Lines have to date been subcultured up to 180 times and the doubling time varies between 26 hr and 3 weeks. Immunocytochemically the coexpression of cytokeratin (predominantly simple-epithelial cytokeratin polypeptides) and vimentin intermediate filaments was detectable in all cell lines, but three lines (EC-MZ-5, 9, 11) expressed vimentin only at low level. By transmission electron microscopy the tumor cells exhibited features of epithelial differentiation. After subcutaneous transplantation into nude mice three lines (EC-MZ-1, 2, 5) produced slow-growing tumors. The histological classification of these tumors ranged from moderately differentiated adenocarcinoma to undifferentiated carcinoma and closely corresponded to the original tumor. Even after long-term in vitro culture, without any addition of estrogens to the culture medium, the moderately differentiated receptor-positive cell line (EC-MZ-2) retained its morphological differentiation. The cells were propagated without estrogens in the culture medium. The estrogen and progesterone receptor levels of cultured cells were determined. Three lines (EC-MZ-1, 2, 3) were positive for the progesterone receptor in low passage number only, the other cell lines were negative for both receptors. The transplantable lines were investigated for hormonal receptor expression in ovariectomized nude mice. In the moderately differentiated cell line (EC-MZ-2) we observed an enhanced expression of the estrogen receptor under optimal stimulation of the nude mouse with estradiol benzoate. There was no effect on the expression of the progesterone receptor.
V Möbus, and
C D Gerharz, and
M Mitze, and
R Moll, and
K Pollow, and
T Kother, and
P G Knapstein, and
R Kreienberg
June 1986,
British journal of cancer,
V Möbus, and
C D Gerharz, and
M Mitze, and
R Moll, and
K Pollow, and
T Kother, and
P G Knapstein, and
R Kreienberg
January 1991,
Annals of the New York Academy of Sciences,
V Möbus, and
C D Gerharz, and
M Mitze, and
R Moll, and
K Pollow, and
T Kother, and
P G Knapstein, and
R Kreienberg
September 2010,
International journal of oncology,
V Möbus, and
C D Gerharz, and
M Mitze, and
R Moll, and
K Pollow, and
T Kother, and
P G Knapstein, and
R Kreienberg
January 2004,
European journal of gynaecological oncology,
V Möbus, and
C D Gerharz, and
M Mitze, and
R Moll, and
K Pollow, and
T Kother, and
P G Knapstein, and
R Kreienberg
March 1995,
Human cell,
V Möbus, and
C D Gerharz, and
M Mitze, and
R Moll, and
K Pollow, and
T Kother, and
P G Knapstein, and
R Kreienberg
October 1990,
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
V Möbus, and
C D Gerharz, and
M Mitze, and
R Moll, and
K Pollow, and
T Kother, and
P G Knapstein, and
R Kreienberg
May 2005,
Reproductive biomedicine online,
V Möbus, and
C D Gerharz, and
M Mitze, and
R Moll, and
K Pollow, and
T Kother, and
P G Knapstein, and
R Kreienberg
January 1987,
Virchows Archiv. B, Cell pathology including molecular pathology,
V Möbus, and
C D Gerharz, and
M Mitze, and
R Moll, and
K Pollow, and
T Kother, and
P G Knapstein, and
R Kreienberg
January 2024,
Frontiers in veterinary science,
V Möbus, and
C D Gerharz, and
M Mitze, and
R Moll, and
K Pollow, and
T Kother, and
P G Knapstein, and
R Kreienberg
November 1982,
The Journal of urology,
